XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 64,133 $ 187,026
Investments in marketable securities, current portion 347,388 143,325
Accounts receivable 5,974 1,304
Inventories 7,272 3,416
Prepaid expenses and other current assets 6,246 4,993
Total current assets 431,013 340,064
Investments in marketable securities 15,109  
Property and equipment, less accumulated depreciation of $13,273 and $12,495 at September 30, 2017 and December 31, 2016, respectively 9,641 9,816
In-process research & development 23,000 486,700
Goodwill 197,797 197,797
Other non-current assets 4,219 2,468
Total Assets 680,779 1,036,845
Current liabilities:    
Accounts payable, accrued expenses, and other current liabilities 53,709 41,008
Deferred reimbursements, current portion 6,250 13,850
Contingent consideration payable, current portion 8,200 56,101
Total current liabilities 68,159 110,959
Deferred reimbursements 16,906 21,906
Convertible notes 161,635 154,464
Contingent consideration payable 12,900 213,621
Deferred income taxes 9,186 173,771
Other non-current liability 2,313 1,973
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value, 250,000,000 shares authorized, 165,491,141 and 142,691,986 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 1,707 1,480
Additional paid-in capital 1,387,767 1,120,156
Accumulated other comprehensive loss:    
Foreign currency translation adjustment (1,367) 1,945
Unrealized gain on available-for-sale securities (101) 102
Warrants 16,076 16,076
Accumulated deficit (994,402) (779,608)
Total stockholders' equity 409,680 360,151
Total Liabilities and Stockholders' Equity $ 680,779 $ 1,036,845